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Several 2-(substituted aryl)-3-(N l-irnidazolylacetamidyl)-4-oxo-thiazolidines 4 and 2-(substituted
aryl, -3-(N l-irnidazolylacetamidyl)-5-arylidine-4-oxothiazolidines 5 have been synthesised and tested
for their biological activity. Their structures have been elucidated on the basis of their elemental analysis
and spectral data.
Imidazole derivatives possess potent biological
activities such as anthelmintic, antiamoebic,
antiparasitic, antiprotozoal, anticonvulsant, anti-
inflammatory, tripanocidal, analgesic, antifungal
and antibacterial 1-3. We have reported earlier the
synthesis and biological activity of several
compounds derived from imidazole nucleus?".
4-0xo-thiazolidines and their 5-arylidine deri-
vatives also possess a variety of therapeutic
activity''". The incorporation of 4-oxo-thiazolidine







work has been found to enhance the activity. Hence
in the present study the 1st position in imidazole
nucleus having a secondary amine group, was used
as the target, for chemical modification (Scheme I).
The compounds have been evaluated for their
biological activity.
Imidazole on electrophilic substitution by ethyl
chloroacetate under reflux condition gave ethyl
-N I-imidazolyl acetate 1 which on amination with
hydrazine hydrate afforded N I-imidazolyl acetyl
hydrazine 2. Compound 2 on condensation with




(5a-h) RI ••R2 = aryl/substituted aryl
Scheme I
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Table II-Antifungal activity of the compounds 4 antiS
c. pannicai A. niger R. oryzae
100 ppm 500 ppm 100 ppm 500 ppm 100 ppm 500 ppm
4a + + ++ +
4b + ++ + + +
4c + ++ + + ++
4d + + +
4e + + ++ +
4f ++ +++ ++ +++ + ++
4g + +++ ++ +++ + ++
~ ++ +++ + ++ + ++
Sa + ++ + ++ +
Sb ++ +++ ++ ++ + ++
~ ++ +++ ++ ++ + ++
Sd + + ++ + ++
Se + ++ + ++ ++
Sf ++ ++++ ++ +++ ++ +++
Sg ++ ++++ ++ +++ + ++
Sh ++ +++ + +++ ++ +++
Gf ++ ++++ ++ ++++ ++ ++++
Inhibition diameter in mm. (-): IImm.; (+),11-14 mm; (++),15-18 mm; (+++),19-21 mm and (++++),22-25 mm.
Of: Grseofulvin, .
various aromatic aldehydes yielded N I-(phenyli-
dine hydrazidomethyl)-imidazole 3. Compound 3
on reaction with thioglycolic acid underwent
dehydration annulation to afford 2-(substituted
aryl)-3-(N -imidazolyl acetamidyl)-4-oxo-thiazo-
lidine 4 which on the application of the
Knoevenogel reaction with various aldehydes
yielded 2-(substituted aryl)-3-(N -imidazolyl
acetamidyl)-5-arylidine-4-oxo-thiazolidines 5. The
structure of the product were confirmed by spectral
data and elemental analysis (cf. Table I).
Biological activity
Antifungal activity
The antifungal activity of the compounds 4a-b
and 5a-b were determined by filter paper disc
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Table III-Antibacterial activity of the compounds 4 and 5
Compd S. dysenteriae S. aureus
50 ppm 100 ppm 50ppm 100ppm
S.flexneri
50 ppm 100 ppm
4a ++ + + ++
4b + ++ ++ +
4c + ++ + ++ +
4d ++ + ++ + ++
4e + + + ++
4f + ++ + ++ + ++
4g + ++ + ++ + ++
~ + + ++ ++
Sa ++ +++ + ++ ++ +++
Sb ++ +++ ++ +++ ++ +++
Sc ++ +++ ++ +++ ++ +++
Sd + +++ ++ +++ ++ +++
Se + ++ ++ +++ ++ ++++
Sf ++ ++++ ++ ++++ ++ +++
Sg ++ +++ + +++ + ++
Sb + ++ ++ +++ + +++
Std. ++ +++++ ++ ++++ ++ +++++




















PAS : Per cent analgesia sease
Stand. Acetyl salicylic acid
Table IV-Anti-inflammatory and analgesic activity of the compounds 4 and 5
Anti-inflammatory activity Analgesi'c activity
Dose Per cent Dose PAS after





































method'? against the fungi Crysosporium panical,
Aspergillus niger and Rizopus oryzae at 100 and
500 ppm concentrations using Griseofulvin as a
standard drug at same concentration for
comparison. Results are presented in Table IT.
method'" against the following bacteria Shigella
dysenteriae, Streptococcus aureus and Shigella
jlexneri at 50 and 100 ppm concentrations using
streptomycin as a standard drug at same
concentration for comparison. Results are
presented in Table ITI.
Antibacterial activity
The antibacterial activity of the compounds 4a-b
and 5a-b was determined by. filter paper disc
Anti-inflammatory activity
Rat paw oedema method was used for evaluating
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anti-inflammatory activity of the compounds 4a-h
and Sa-h using carrageenan as an inflammatory
agent (50 mg/kg body weight in albino rats
weighing 100-120 g). The rat paw oedema was
produced by the method of Winter et al. II. The
standard drug acetyl salicylic acid was used for
comparision. The percent inhibition of
inflammation was calculated by applying
Newbould formula. Results are presented in Table
IV.
Analgesic activity
Compounds 4a-h and 5a-h were also screened
for their analgesic activity. A group of albino rats
were treated intraperitoneally with 100 mg/kg body
weight of the aqueous suspension of the
synthesised compounds. The method'f of Eddy and
Leimbach using a Techno heated plate analgesic
apparatus was used. The standard drug acetyl
salicylic acid was used for comparision. The results
are presented in Table IV.
Experimental Section
Melting points were determined in an open
capillary tubes and are uncorrected. IR spectra
were recorded in KBr on an Acculab-10
spectrophotometer (vrnaxin cm') and IHNMR on
Brucker WM 400 spectrometer (400 MHz, CDCl3,
chemical shifts in 0, ppm) using TMS as an internal
standard.
Ethyl N -imidazol acetate la.
Equimolar solution of imidazole (0.2 mole) in
dry acetone (80 mL) and ethyl chloroacetate (0.2
mole) in the presence of anhyd. K2C03 (5 g) was
refluxed on a water bath for about 10 hr, cooled
and the solid thus obtained was filtered, dried and
crystallized from ethanol to give 1, yield 84%, m.p.
48-49° (Found : C, 54.50, H, 6.42; N, 18.13.
C7HlON202 requires C, 54.54; H, 6.49; N, 18.18%);
IR: 1730 (C=O ester), 1460(-N-CHr); IHNMR:
1.20(t, 3H, -COOCH2.CH3), 3.60(s, 2H, -N- CH2),
4.10(q, 2H, -COOCH2.CH3) and 6.90-7.00(d, 2H,
Ar-H), 7.18(s, 1H, Ar-H).
N '<imidazole acetyl hydrazine 2a. A mixture of
compound 1 (0.15 mole) and hydrazine hydrate
(0.15 mole) in l,4-dioxane (60 mL) was refluxed
on a water bath for about 16 hr. It was cooled and
filtered when a colourless substance separated out
which was crystallized from ethanol to give 2,
yield 82%, m.p. 37-38° (Found: C, 42.81; H, 5.69;
N, 39.87. CsHsN40 requires C, 42.85; H, 5.71; N,
40.00%); IR : 3340(-NH-NH2)' 1670 (C=O amido);
IHNMR: 2.50 (s, 2H-NH2)' 3.56(s, 2H, -N-CH2-)'
6.90-7.00(d, 2H, Ar-H), 7.20 (s, 1H, Ar-H).
N'{phenylidenehydrazido methylj-imidazole 3a.
A solution of compound 2 (0.1 mole) in CHCh (50
mL), benzaldehyde (0.1 mole) and 4-5 drops of gl.
acetic acid was refluxed on a water-bath for about
8 hr, cooled and evaporated to obtain a residue
which was crystallized from ethanol to give 3a,
yield 79%, m.p. 65-66° (Found: C,63.12; H, 5.21;
N, 24.53. C12H12N40 requires C, 63.16; H, 5.26; N,
24.56%); IR : 3332 (-NH-), 1660 (C=O amido),
1620 (-CH=N-); IHNMR : 3.70(s, 2H, N-CHr),
4.40(s, 1H, -N=NH-), 7.00-7.80(m, 8H, Ar-H) and
8.40(s, 1H, -CO-NH-).
Likewise, other N -(arylidine hydrazidomethyl)-
imidazoles, 3b-h were prepared by treating 2 with
various aldehyde and their physical data are given
in Table 1.
2-phenyl-3-{N' -imidazolyl-acetamidylt-s-oxo-thia-
zolidine 4a. A mixture of compound 3a (0.01 mole)
in THF (30 mL) and mercapto acetic acid (0.01
mole) with a pinch of anhyd. ZnCL2 was refluxed
for about 10 hr on a water-bath. The separated solid
was filtered and crystallized from ethanol to give
4a, yield 75%, m.p. 74.75° (Found: C, 55.60; H,
4.63; N, 18.52. CI4HI4N402S requires C, 55.63; H,
4.64; N, 18.54%); IR : 3350 (-NH-), 1711 (C=O
cyclic), 1657 (C=O, amidyl); IHNMR : 3.25(s, IH,
-CH-N), 3.65 (s, 2H, -CH2-S-), 3.72 (s, 2H, -N-
CHr), 6.90-7.80 (m, 8H, Ar-H) and 8.49 (s, lH, -
CO-NH-).
Compounds 4b-h were prepared similarly from
3b-h and their physical data are given in Table I.
2-phenyl-3-(N'-imidazolylacetamidyl)-5-(benzy-
lidinel-d-oxo-thia-zolidine 5a. Equimolar solution
of 4a (0.01 mole) and benzaldehyde (0.01 mole) in
benzene (25 mL) in presence of C2HsONa was
refluxed for about 8 hr, cooled and poured into ice
cooled water. The solid thus obtained was filtered,
dried and crystallized from ethanol to give 5a :
yield 70%, m.p. 89-90° (Found: C, 64.60; H, 4.61;
N, 14.34. C21HlSN402S requires C, 64.62; H, 4.62;
N, 14.36%); IR : 3542-(-NH-), 1715 (C=O cyclic),
1652(C=O. amidyl), 1635 (C=CH-); IHNMR :
3.20(s, IH, -CH-N), 3.72(s, 2H, -N-CHz-), 5.22(s,
1H, C=CH-Ar), 7.00-8.00 (m, 13H, Ar-H) and 8.50
(s, IH, -CO-NH-).
Similarly, other thiazolidines, 5b-h were
prepared from 4b-h and their physical data are
given in Table 1.
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